Raymond James Financial Inc Exact Sciences Corp Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 171,053 shares of EXAS stock, worth $9.28 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
171,053Holding current value
$9.28 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
661Shares Held
162MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$964 Million0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$860 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$778 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$655 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$363 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $9.61B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...